UK Pharmaceutical Industry Development Report
The UK pharmaceutical market and industry is analysed in this report, covering end user markets for prescription medicines and over the counter products as well as the apparent UK markets for basic pharmaceuticals and pharmaceutical preparations. Market trends are fully detailed, including appraisal of demographic factors, NHS expenditure trends, generic drug activity and outsourcing and the impact of PPRS.
The report contains five year historical data, current market conditions and influences, together with a five year sector forecast by MBD analysts. The data is clearly presented and illustrated.
The report contains five year historical data, current market conditions and influences, together with a five year sector forecast by MBD analysts. The data is clearly presented and illustrated.
1. EXECUTIVE SUMMARY
2. INTRODUCTION
2.1 Definitions
2.2 Abbreviations
2.3 Market Positioning
2.4 UK Economy
2.5 Market Factors
3. MARKET SIZE AND TRENDS
3.1 Chapter Summary
3.2 Market Size
3.3 Market Segmentation
3.3.1 Prescription Medicines
3.3.2 OTC Medicines
3.4 Market Trends
3.4.1 Demographics
3.4.2 Expenditure
3.4.3 Distribution
3.4.4 Generics
3.4.5 Outsourcing
3.4.6 Parallel Trade
3.4.7 Herbal Medicines
4. SUPPLY SOURCES
4.1 Chapter Summary
4.2 Production
4.2.1 Overview
4.2.2 Segmentation
4.3 Imports
4.3.1 Overview
4.3.2 Segmentation
4.4 Exports
4.4.1 Overview
4.4.2 Segmentation
4.5 Trade Surplus/Deficit
5. INDUSTRY STRUCTURE
5.1 Chapter Summary
5.2 Industry Development
5.3 Structure by Employment
5.4 Structure by Turnover
5.5 Company Profiles
5.5.1 AstraZeneca
5.5.2 Bristol-Myers Squibb Pharmaceuticals
5.5.3 Celltech Group
5.5.4 Eli Lilly & Co
5.5.5 GE Healthcare
5.5.6 GlaxoSmithKline
5.5.7 Johnson & Johnson Medical
5.5.8 Merck Sharp & Dohme
5.5.9 Novartis UK
5.5.10 Pfizer
5.5.11 Pharmacia
5.5.12 Roche Products
5.5.13 Shire Pharmaceuticals Group
5.5.14 Unichem
5.5.15 3M Health Care
6. FORECAST
6.1 Chapter Summary
6.2 Market Size
6.3 Market Segmentation
6.4 Industry
7. FURTHER SOURCES & CONTACTS
7.1 Trade Associations
7.2 Trade Magazines
7.3 Trade Exhibitions
2. INTRODUCTION
2.1 Definitions
2.2 Abbreviations
2.3 Market Positioning
2.4 UK Economy
2.5 Market Factors
3. MARKET SIZE AND TRENDS
3.1 Chapter Summary
3.2 Market Size
3.3 Market Segmentation
3.3.1 Prescription Medicines
3.3.2 OTC Medicines
3.4 Market Trends
3.4.1 Demographics
3.4.2 Expenditure
3.4.3 Distribution
3.4.4 Generics
3.4.5 Outsourcing
3.4.6 Parallel Trade
3.4.7 Herbal Medicines
4. SUPPLY SOURCES
4.1 Chapter Summary
4.2 Production
4.2.1 Overview
4.2.2 Segmentation
4.3 Imports
4.3.1 Overview
4.3.2 Segmentation
4.4 Exports
4.4.1 Overview
4.4.2 Segmentation
4.5 Trade Surplus/Deficit
5. INDUSTRY STRUCTURE
5.1 Chapter Summary
5.2 Industry Development
5.3 Structure by Employment
5.4 Structure by Turnover
5.5 Company Profiles
5.5.1 AstraZeneca
5.5.2 Bristol-Myers Squibb Pharmaceuticals
5.5.3 Celltech Group
5.5.4 Eli Lilly & Co
5.5.5 GE Healthcare
5.5.6 GlaxoSmithKline
5.5.7 Johnson & Johnson Medical
5.5.8 Merck Sharp & Dohme
5.5.9 Novartis UK
5.5.10 Pfizer
5.5.11 Pharmacia
5.5.12 Roche Products
5.5.13 Shire Pharmaceuticals Group
5.5.14 Unichem
5.5.15 3M Health Care
6. FORECAST
6.1 Chapter Summary
6.2 Market Size
6.3 Market Segmentation
6.4 Industry
7. FURTHER SOURCES & CONTACTS
7.1 Trade Associations
7.2 Trade Magazines
7.3 Trade Exhibitions
